Overview

Gender

male

Bob Zuk, Founder and Chief Technology Officer, is respected in the life science and clinical diagnostics industries for his repeated success in integrating biochemistry with device design to provide elegantly simple solutions to challenging analytical problems. His contributions encompass diverse applications—from biosensors on the Octet platform (FortéBio) and Threshold instrument (Molecular Devices) for life science applications, to ultrasound enhanced gene delivery in myocardial and skeletal angiogenesis (Pharmasonics), to point-of-care cardiac marker tests (First Medical) and AccuLevel (Syva), one of the first commercially available, instrument-free, quantitative assay for therapeutic drug monitoring. Bob has a portfolio of more than 60 U.S. patents and pending applications. He received his B.S. in Biology from University of California, Riverside.